"Designing Growth Strategies is in our DNA"

Pet Cancer Therapeutics Market Size, Share and Global Trend By Therapy (Chemotherapy, Radiation Therapy, Immunotherapy), By Animal Type (Canine, Feline, Equine), By Cancer Type (Mast Cell Cancer, Lymphoma, Melanoma), By Distribution Channel (Veterinary Hospitals & Clinical Pharmacies, Online Pharmacies, Retail Pharmacies), and Geography Forecast till 2026

Region : Global | Report ID: FBI100678 | Status : Ongoing

 

KEY MARKET INSIGHTS

Cancer in pets is one of the major causes of death in pets globally. Cancer is defined as the uncontrolled growth of abnormal cells in some part of the body and occurs across humans and animals. Pets, these days have better chances of being diagnosed with cancer and thus, leading to early adoption of treatment plans, and improved chances of survival. Pets are first diagnosed with neoplasia, which too refers to the uncontrolled growth of tissues or cells known as neoplasm and then leading to cancer. According to The Veterinary Cancer Society, cancer is the leading cause of death in 47% of dogs, especially dogs over age ten, and 32% of cats every year.


Increasing prevalence of pet cancer, increasing incidence of tumors or neoplasia in pets, and an increase in pet ownership are some of the factors driving the growth of the global pet care therapeutics market. Additionally, advances in diagnostic procedures, easy accessibility, and affordability of treatment, increasing awareness of animal health and welfare and increasing animal adoption are some of the factors driving the growth of the global pet care therapeutics market. According to Animal Cancer Foundation, there are 65 million dogs and 35 million cats in the U.S., out of which every year, there are 6 million new cancer diagnosed in these pets. These trends combined with the other factors are expected to positively drive the growth of the pet care therapeutics market.

To gain extensive insights into the market, Request for Customization


However, increasing animal healthcare costs, lack of diagnosis of cancer in pets and the associated side effects of treatment options are some of the factors restraining the growth of the global pet care therapeutics market.


Key Players Covered


Some of the major companies that are present in the global pet cancer therapeutics market are Boehringer Ingelheim International GmbH, ELIAS Animal Health, Karyopharm Therapeutics, Aratana Therapeutics, Inc., Regeneus Ltd, VetDC and Zoetis Services LLC., and others.


SEGMENTATION






























SEGMENTATION



 DETAILS



By Therapy



· Chemotherapy


· Radiation Therapy


· Immunotherapy


· Targeted Therapy


· Combination Therapy


· Others



By Animal Type



· Canine


· Feline


· Equine


· Others



By Cancer Type



· Mast Cell Cancer


· Lymphoma


· Melanoma


· Squamous Cell Carcinoma


· Mammary Cancer


· Anal Sac Carcinoma


· Others



By Distribution Channel



· Veterinary Hospitals & Clinical Pharmacies


· Online Pharmacies


· Retail Pharmacies


· Others



By Geography



· North America (USA and Canada)


· Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)


· Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)


· Latin America (Brazil, Mexico and Rest of Latin America)


· Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)



 


In 2018, among cancer type, mast cell cancer dominated the global pet cancer therapeutics market due to increased prevalence of the mast cell cancer and availability of drugs for its treatment. This segment is projected to grow at comparatively lower CAGR during the forecast period.


Key Insights





  • Prevalence of Pet Cancer, By Key Regions
  • Overview of Pet Ownership Rates by Key Countries
  • Pipeline Analysis, Key Players
  • Recent Industry Developments Such as Partnerships, Mergers, and Acquisitions

Regional Analysis:


North America dominated the global pet cancer therapeutics market in 2018, owing to a number of factors such as the rising rate pet adoption, increasing prevalence of pet cancer, advancements in diagnostic procedures, increasing expenditure on animal health, and increasing animal health awareness. Asia Pacific is anticipated to grow at a significant CAGR during the forecast period. This is due to increasing pet animal pool, increasing incidence of pet cancer, increasing pet adoption rates, increasing awareness of animal welfare, rising disposable incomes and introduction of new pet cancer therapeutics.


Key Industry Developments




  • In March 2019, Pfizer Inc., received FDA approval for the Palladia, the first drug officially approved for use in treating dog cancer. This drug will be available in the market by the end of 2020.
  • In October 2017, VETCO, launched animal cancer treatment novel drug Antican in Taiwan. Antican, the animal cancer treatment novel drug, has been approved by the COA, the Taiwanese Council of Agriculture and, is the 3rd approved anticancer drug in global and 1st in Asia.

Pet Cancer Therapeutics Market Size, Share and Global Industry Trend Forecast till 2026
  • Ongoing
  • 2019
  • 2016-2018

    CHOOSE LICENSE TYPE

  • 4850
    6850
    8850

Personalize this Research

  • Granular Research on Specified Regions or Segments
  • Companies Profiled based on User Requirement
  • Broader Insights Pertaining to a Specific Segment or Region
  • Breaking Down Competitive Landscape as per Your Requirement
  • Other Specific Requirement on Customization
Request Customization Banner

Healthcare Clients

DUPONT
Natus-Medical
chong-kun-dang
baxter
lpsos

Client Testimonials

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . More info.
X